Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Evaluation of Head and Neck Paragangliomas by Computed Tomography in Patients with Pheochromocytoma-Paraganglioma Syndromes.

Michałowska I, Lewczuk A, Ćwikła J, Prejbisz A, Swoboda-Rydz U, Furmanek MI, Szperl M, Januszewicz A, Pęczkowska M.

Pol J Radiol. 2016 Oct 31;81:510-518. eCollection 2016.

2.

Endocrine tumors associated with the vagus nerve.

Varoquaux A, Kebebew E, Sebag F, Wolf K, Henry JF, Pacak K, Taïeb D.

Endocr Relat Cancer. 2016 Sep;23(9):R371-9. doi: 10.1530/ERC-16-0241. Epub 2016 Jul 12. Review.

3.

Identification of eight novel SDHB, SDHC, SDHD germline variants in Danish pheochromocytoma/paraganglioma patients.

Bennedbæk M, Rossing M, Rasmussen ÅK, Gerdes AM, Skytte AB, Jensen UB, Nielsen FC, Hansen TV.

Hered Cancer Clin Pract. 2016 Jun 8;14:13. doi: 10.1186/s13053-016-0053-6. eCollection 2016.

4.

SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery.

Saxena N, Maio N, Crooks DR, Ricketts CJ, Yang Y, Wei MH, Fan TW, Lane AN, Sourbier C, Singh A, Killian JK, Meltzer PS, Vocke CD, Rouault TA, Linehan WM.

J Natl Cancer Inst. 2016 Jan;108(1). doi: 10.1093/jnci/djv287.

5.

68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.

Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, Nambuba J, Herscovitch P, Sadowski SM, Fojo AT, Buchmann I, Kebebew E, Pacak K.

J Nucl Med. 2016 Feb;57(2):186-91. doi: 10.2967/jnumed.115.161018. Epub 2015 Nov 12.

6.

Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics.

Varoquaux A, le Fur Y, Imperiale A, Reyre A, Montava M, Fakhry N, Namer IJ, Moulin G, Pacak K, Guye M, Taïeb D.

Endocr Relat Cancer. 2015 Aug;22(4):M1-8. doi: 10.1530/ERC-15-0246. Epub 2015 Jun 26.

7.

Current approaches and recent developments in the management of head and neck paragangliomas.

Taïeb D, Kaliski A, Boedeker CC, Martucci V, Fojo T, Adler JR Jr, Pacak K.

Endocr Rev. 2014 Oct;35(5):795-819. doi: 10.1210/er.2014-1026. Epub 2014 Jul 17. Review.

8.

Diagnosis and management of multiple paragangliomas of the head and neck.

Szymańska A, Szymański M, Czekajska-Chehab E, Gołąbek W, Szczerbo-Trojanowska M.

Eur Arch Otorhinolaryngol. 2015 Aug;272(8):1991-9. doi: 10.1007/s00405-014-3126-z. Epub 2014 Jun 12.

9.

Genetic testing in head and neck paraganglioma: who, what, and why?

Sridhara SK, Yener M, Hanna EY, Rich T, Jimenez C, Kupferman ME.

J Neurol Surg B Skull Base. 2013 Aug;74(4):236-40. doi: 10.1055/s-0033-1342924. Epub 2013 Apr 12.

10.

18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas.

Blanchet EM, Gabriel S, Martucci V, Fakhry N, Chen CC, Deveze A, Millo C, Barlier A, Pertuit M, Loundou A, Pacak K, Taïeb D.

Eur J Clin Invest. 2014;44(3):325-32. doi: 10.1111/eci.12239.

11.

Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.

Taïeb D, Varoquaux A, Chen CC, Pacak K.

Semin Nucl Med. 2013 Nov;43(6):462-73. doi: 10.1053/j.semnuclmed.2013.06.005. Review.

12.

Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.

Cama A, Verginelli F, Lotti LV, Napolitano F, Morgano A, D'Orazio A, Vacca M, Perconti S, Pepe F, Romani F, Vitullo F, di Lella F, Visone R, Mannelli M, Neumann HP, Raiconi G, Paties C, Moschetta A, Tagliaferri R, Veronese A, Sanna M, Mariani-Costantini R.

Acta Neuropathol. 2013 Oct;126(4):575-94. doi: 10.1007/s00401-013-1165-y. Epub 2013 Aug 18.

13.

Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.

Shankavaram U, Fliedner SM, Elkahloun AG, Barb JJ, Munson PJ, Huynh TT, Matro JC, Turkova H, Linehan WM, Timmers HJ, Tischler AS, Powers JF, de Krijger R, Baysal BE, Takacova M, Pastorekova S, Gius D, Lehnert H, Camphausen K, Pacak K.

Neoplasia. 2013 Apr;15(4):435-47.

14.

Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.

Fishbein L, Merrill S, Fraker DL, Cohen DL, Nathanson KL.

Ann Surg Oncol. 2013 May;20(5):1444-50. doi: 10.1245/s10434-013-2942-5. Epub 2013 Mar 20.

15.

Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.

Johnston JJ, Rubinstein WS, Facio FM, Ng D, Singh LN, Teer JK, Mullikin JC, Biesecker LG.

Am J Hum Genet. 2012 Jul 13;91(1):97-108. doi: 10.1016/j.ajhg.2012.05.021. Epub 2012 Jun 14.

16.

Head and neck paragangliomas: clinical and molecular genetic classification.

Offergeld C, Brase C, Yaremchuk S, Mader I, Rischke HC, Gläsker S, Schmid KW, Wiech T, Preuss SF, Suárez C, Kopeć T, Patocs A, Wohllk N, Malekpour M, Boedeker CC, Neumann HP.

Clinics (Sao Paulo). 2012;67 Suppl 1:19-28. Review.

17.

Paragangliomas and paraganglioma syndromes.

Boedeker CC.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2011;10:Doc03. doi: 10.3205/cto000076. Epub 2012 Apr 26.

18.

Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background.

Fishbein L, Nathanson KL.

Cancer Genet. 2012 Jan-Feb;205(1-2):1-11. doi: 10.1016/j.cancergen.2012.01.009. Review.

19.

Recurrent paraganglioma of Meckel's cave: Case report and a review of anatomic origin of paragangliomas.

Prajsnar A, Balak N, Walter GF, Stan AC, Deinsberger W, Tapul L, Bayindir C.

Surg Neurol Int. 2011;2:45. doi: 10.4103/2152-7806.79763. Epub 2011 Apr 19.

20.

Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.

Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K.

Clin Chem. 2011 Mar;57(3):411-20. doi: 10.1373/clinchem.2010.153320. Epub 2011 Jan 24.

Supplemental Content

Support Center